CA
NZ
UK
AU
IND
US
Conexeu Sciences Inc. (NASDAQ: CNXU) recorded a net loss of $7,725,651 ($7.73M) for the three months ended July 31, 2026, compared with a $1,298,570 loss in the comparable period. The nine-month net loss reached $11,748,757, versus $2,046,684 previously.
ECO SCIENCE SOLUTIONS’ cash dropped to $15,551 at July 31, 2026, from $32,699 at January 31, 2026. Total currentAssetsstood at $19,223, while total assets were $105,334.
HeartSciences Inc. (NASDAQ: HSCS) reported quarterly revenue of $2 thousand for the three months ended July 31, 2026, unchanged from the comparable period. Total operating expenses climbed 57% to $2,940 thousand. Interest expense rose 28% to $235 thousand from $184 thousand. Other income was …
VALUE LINE INC (NASDAQ: VALU) reported total publishing revenue of $8.051 million for the three months ended July 31, 2026, down 6.4% from the comparable period. Net income fell 27.9% to $4.655 million, or $0.50 per share, while income from operations declined 31.4% to …
Benitec Biopharma Inc. (NASDAQ: BNTC) recorded $51,192 thousand in total operating expenses for the year ended June 30, 2026. The company generated or recognized noRevenueduring the year. The outlook places expense growth alongside the company’s ongoing clinical development spending. Benitec Biopharma also identified higher …
A Form 4 filed on September 14, 2026, disclosed that Jose Francisco Flores Junco, Chief Financial Officer of Securitize Corp. (NYSE:SECZ), was awarded 161,140 Restricted Stock Units on September 10, 2026, at a price of $0.
Carlos Francisco Domingo Soriano, Executive Chairman and CEO of Securitize Corp. (NYSE:SECZ), filed a Form 4 on September 12, 2026, disclosing the acquisition of 318,302 Restricted Stock Units on September 10, 2026, at a price of $0.
William Dawson Miller, Chief Operating Officer of Securitize Corp. (NYSE:SECZ), filed a Form 4 on September 12, 2026, disclosing the acquisition of 109,913 restricted stock units on September 10, 2026.
Value Line, Inc. filed its Form 10-Q for the quarterly period ended July 31, 2026 with the Securities and Exchange Commission on September 14, 2026, reporting financial results for the first fiscal quarter of its year ending April 30, 2027.
Trilogy Metals Inc. filed a Form 8-K with the SEC on September 14, 2026, reporting the September 11, 2026 closing of a strategic equity investment by the United States Department of War, pursuant to an Investment Agreement dated August 28, 2026.
Please wait processing your request...